Skip to main content

Table 2 Characteristics of patients at hospital admission and treatment by causative agent

From: In-hospital management of children with bacterial meningitis in Italy

 

N. meningitidis

S. pneumoniae

Other

Not known

p-value

Total

 

N. (29)

N. (17)

N. (10)

N. (29)

 

N. (85)

Median age at onset yrs - (IQR)

4.0 (1.5 - 7.6)

1.4 (0.5 - 4.6)

0.6 (0.3 - 7.0)

5.2 (0.4 - 8.2)

0.085

3.3 (0.5 - 7.1)

Median interval days between onset and hospital admission - (IQR)

1 (1-2)

3 (2-3)

1 (0-2)

1 (1-4)

0.005

1 (1-3)

Number of patients treated with antibiotics prior to hospitalization - (%)

14 (48.3)

8 (47.1)

2 (20.0)

18 (62.1)

0.238

42 (49.4)

Median interval hours between suspected diagnosis of meningitis and first in-hospital antibiotic administration - (IQR)

1 (1-2)

1 (1-2)

1 (1-2)

1 (1-2)

0.995

1 (1-2)

In vitro susceptibility testing available <3 days since admission, excluded unknown agent - (%)

22 (75.9)

12 (70.6)

8 (80.0)

-

0.691

42 (75.0)

Type of antibiotic administered - (%)

    

<0.001

 

III-generation cephalosporin

18 (62.1)

2 (11.8)

1 (10.0)

16 (55.2)

 

29 (34.1)

III-generation cephalosporin + glycopeptides

3 (10.3)

7 (41.2)

1 (10.0)

1 (3.4)

 

17 (20.0)

III-generation cephalosporin + other antibiotics

8 (27.6)

8 (47.1)

5 (50.0)

11 (37.9)

 

10 (11.8)

Other

0 (0.0)

0 (0.0)

3 (30.0)

1 (3.4)

 

29 (34.1)

Number of patients treated with dexamethasone - (%)

15 (51.7)

14 (82.4)

6 (60.0)

19 (65.5)

0.222

54 (63.5)

Number of patients who received dexamethasone within 1 hour of antibiotic - (%)

9 (31.0)

10 (58.8)

5 (50)

10 (34.5)

0.544

34 (40)

Median duration days of dexamethasone treatment - (IQR)

6 (4-12)

4 (4-12)

7 (4-11)

6 (4-10)

0.951

6 (4 - 12)

  1. IQR: interquartile range.